Matches in SemOpenAlex for { <https://semopenalex.org/work/W2322176912> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2322176912 endingPage "29" @default.
- W2322176912 startingPage "24" @default.
- W2322176912 abstract "In Brief Purpose: To report eight cases of long-term successful treatment of choroidal neovascularization because of ocular histoplasmosis syndrome with intravitreal anti–vascular endothelial growth factor agents. Methods: Retrospective case series. This article reviewed the course of eight eyes in seven patients who underwent intravitreal injection of bevacizumab and/or ranibizumab for treatment of choroidal neovascularization secondary to ocular histoplasmosis syndrome. Outcomes were assessed using pre- and post-anti–vascular endothelial growth factor visual acuities. Results: Eight eyes in seven patients were found to have new ocular histoplasmosis syndrome–associated subfoveal choroidal neovascularization lesions, as evidenced on clinical examination, fluorescein angiography, and optical coherence tomography. Intravitreal anti–vascular endothelial growth factor injections were used as initial or early treatment with successful resolution of the choroidal neovascularization lesions in most cases. Mean visual acuity improved from 20/60 to 20/47 over an average of 121.4 weeks. Either bevacizumab or ranibizumab was administered with an average of 2.6 injections per year of follow-up. Three eyes (37.5%) experienced a gain in visual acuity with a mean increase of 7.7 lines, 1 eye (12.5%) experienced no change, and 2 eyes (25%) experienced a loss of visual acuity of 2 or more lines. Six eyes (75%) were able to avoid mild visual loss (2 lines or less). Conclusions: Intravitreal anti–vascular endothelial growth factor agents may successfully treat or at least stabilize neovascular complications of ocular histoplasmosis syndrome when used as a first-line treatment. Case series describing eight eyes from seven patients who presented with subfoveal choroidal neovascularization resulting from ocular histoplasmosis treated successfully with intravitreal ranibizumab and/or bevacizumab." @default.
- W2322176912 created "2016-06-24" @default.
- W2322176912 creator A5012469757 @default.
- W2322176912 creator A5026587624 @default.
- W2322176912 creator A5047052383 @default.
- W2322176912 creator A5063313188 @default.
- W2322176912 creator A5067533298 @default.
- W2322176912 date "2014-01-01" @default.
- W2322176912 modified "2023-09-27" @default.
- W2322176912 title "INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR FOR CHOROIDAL NEOVASCULARIZATION IN OCULAR HISTOPLASMOSIS" @default.
- W2322176912 cites W1481978003 @default.
- W2322176912 cites W1983964315 @default.
- W2322176912 cites W1990485663 @default.
- W2322176912 cites W2017593303 @default.
- W2322176912 cites W2019156888 @default.
- W2322176912 cites W2042321005 @default.
- W2322176912 cites W2073559780 @default.
- W2322176912 cites W2123232376 @default.
- W2322176912 cites W4249250897 @default.
- W2322176912 doi "https://doi.org/10.1097/icb.0b013e3182a48bcc" @default.
- W2322176912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25372202" @default.
- W2322176912 hasPublicationYear "2014" @default.
- W2322176912 type Work @default.
- W2322176912 sameAs 2322176912 @default.
- W2322176912 citedByCount "10" @default.
- W2322176912 countsByYear W23221769122015 @default.
- W2322176912 countsByYear W23221769122017 @default.
- W2322176912 countsByYear W23221769122018 @default.
- W2322176912 countsByYear W23221769122019 @default.
- W2322176912 countsByYear W23221769122020 @default.
- W2322176912 countsByYear W23221769122022 @default.
- W2322176912 crossrefType "journal-article" @default.
- W2322176912 hasAuthorship W2322176912A5012469757 @default.
- W2322176912 hasAuthorship W2322176912A5026587624 @default.
- W2322176912 hasAuthorship W2322176912A5047052383 @default.
- W2322176912 hasAuthorship W2322176912A5063313188 @default.
- W2322176912 hasAuthorship W2322176912A5067533298 @default.
- W2322176912 hasConcept C118487528 @default.
- W2322176912 hasConcept C126322002 @default.
- W2322176912 hasConcept C141071460 @default.
- W2322176912 hasConcept C16005928 @default.
- W2322176912 hasConcept C167734588 @default.
- W2322176912 hasConcept C2776694085 @default.
- W2322176912 hasConcept C2777025900 @default.
- W2322176912 hasConcept C2777802072 @default.
- W2322176912 hasConcept C2778257484 @default.
- W2322176912 hasConcept C2778271429 @default.
- W2322176912 hasConcept C2780248432 @default.
- W2322176912 hasConcept C2780318139 @default.
- W2322176912 hasConcept C2780394083 @default.
- W2322176912 hasConcept C2781100027 @default.
- W2322176912 hasConcept C2781359195 @default.
- W2322176912 hasConcept C71924100 @default.
- W2322176912 hasConceptScore W2322176912C118487528 @default.
- W2322176912 hasConceptScore W2322176912C126322002 @default.
- W2322176912 hasConceptScore W2322176912C141071460 @default.
- W2322176912 hasConceptScore W2322176912C16005928 @default.
- W2322176912 hasConceptScore W2322176912C167734588 @default.
- W2322176912 hasConceptScore W2322176912C2776694085 @default.
- W2322176912 hasConceptScore W2322176912C2777025900 @default.
- W2322176912 hasConceptScore W2322176912C2777802072 @default.
- W2322176912 hasConceptScore W2322176912C2778257484 @default.
- W2322176912 hasConceptScore W2322176912C2778271429 @default.
- W2322176912 hasConceptScore W2322176912C2780248432 @default.
- W2322176912 hasConceptScore W2322176912C2780318139 @default.
- W2322176912 hasConceptScore W2322176912C2780394083 @default.
- W2322176912 hasConceptScore W2322176912C2781100027 @default.
- W2322176912 hasConceptScore W2322176912C2781359195 @default.
- W2322176912 hasConceptScore W2322176912C71924100 @default.
- W2322176912 hasIssue "1" @default.
- W2322176912 hasLocation W23221769121 @default.
- W2322176912 hasLocation W23221769122 @default.
- W2322176912 hasOpenAccess W2322176912 @default.
- W2322176912 hasPrimaryLocation W23221769121 @default.
- W2322176912 hasRelatedWork W2024548441 @default.
- W2322176912 hasRelatedWork W2042631328 @default.
- W2322176912 hasRelatedWork W2054981704 @default.
- W2322176912 hasRelatedWork W2070237388 @default.
- W2322176912 hasRelatedWork W2075198919 @default.
- W2322176912 hasRelatedWork W2322176912 @default.
- W2322176912 hasRelatedWork W2559118752 @default.
- W2322176912 hasRelatedWork W2682124582 @default.
- W2322176912 hasRelatedWork W4243304339 @default.
- W2322176912 hasRelatedWork W2599281049 @default.
- W2322176912 hasVolume "8" @default.
- W2322176912 isParatext "false" @default.
- W2322176912 isRetracted "false" @default.
- W2322176912 magId "2322176912" @default.
- W2322176912 workType "article" @default.